zocor 40 mg
orifarm as - simvastatin - tablett, filmdrasjert - 40 mg
zocor 40 mg
orifarm as - simvastatin - tablett, filmdrasjert - 40 mg
poteligeo
kyowa kirin holdings b.v. - mogamulizumab - sezary syndrome; mycosis fungoides - antineoplastiske midler - poteligeo er indisert for behandling av voksne pasienter med mycosis fungoides (mf) eller sézary syndrom (ss) som har mottatt minst én tidligere systemisk terapi.
inegy 10 mg / 20 mg
orifarm as - ezetimib / simvastatin - tablett - 10 mg / 20 mg
inegy 10 mg / 40 mg
orifarm as - ezetimib / simvastatin - tablett - 10 mg / 40 mg
vemlidy 25 mg
orifarm as - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
inegy 10 mg / 20 mg
2care4 aps - ezetimib / simvastatin - tablett - 10 mg / 20 mg
vemlidy 25 mg
abacus medicine a/s - tenofoviralafenamidfumarat - tablett, filmdrasjert - 25 mg
onureg
bristol-myers squibb pharma eeig - azacitidin - leukemi, myeloid, akutt - antineoplastiske midler - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
ezetimibe/simvastatin accord 10 mg / 20 mg
accord healthcare b.v. - ezetimib / simvastatin - tablett - 10 mg / 20 mg